性能参数

产品名称

Urolithin C

规格

10mM*1 mL in DMSO 10mg 50mg 100mg

货号

GOY-Y3332

 含量

>99.00%

CAS

165393-06-6

别名

N/A

化学名

N/A

分子式

C13H8O5

分子量

分子量 244.2

溶解度

DMSO: 125 mg/mL (511.88 mM)

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Urolithin C, a gut-microbial metabolite of Ellagic acid, is a glucose-dependent activator of insulin secretion. Urolithin C is a L-type Ca2+ channel opener and enhances Ca2+ influx. Urolithin C induces cell apoptosis through a mitochondria-mediated pathway and also stimulates reactive oxygen species (ROS) formation[1][2].

Urolithin C (20-100 μM; 1 hour; INS-1 cells) treatment enhances glucose-induced extracellular signal-regulated kinases 1/2 (ERK1/2) activation in INS-1 β-cells[1].Urolithin C significantly inhibits the proliferation of PC12 cells. Urolithin C treatment actively increases the lactate dehydrogenase (LDH) release and lipid peroxidation malondialdehyde (MDA), stimulates reactive oxygen species (ROS) formation and mitochondrial membrane depolarization, and caused calcium dyshomeostasis[2].Urolithin C treatment induces apoptosis and S phase cell cycle arrest[2]. Western Blot Analysis[1] Cell Line: INS-1 cells

The pharmacokinetics of Urolithin C (10 mg/kg; intraperitoneal administration) in male Wistar rat (140-160 g) are studied. The half-life of the terminal part is 11.3 h and the total clearance (CL/F) is 3.41 L/h/kg. The initial volume of distribution (V1/F) and the steady-state volume of distribution (Vss/F) are 0.831 L/kg and 55.6 L/kg, respectively[3].

[1]. Slimane Toubal, et al. Urolithin C Increases Glucose-Induced ERK Activation Which Contributes to Insulin Secretion. Fundam Clin Pharmacol. 2020 Feb 21. [2]. Peipei Yin, et al. Urolithin C, a gut metabolite of ellagic acid, induces apoptosis in PC12 cells through a mitochondria-mediated pathway. RSC Advances. Issue 28, 2017. [3]. Morgane Bayle, et al. Development and Validation of a Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Method for the Determination of Urolithin C in Rat Plasma and Its Application to a Pharmacokinetic Study. J Pharm Biomed Anal. 2016 Nov 30;131:33-39.

2,3,5-**基吡啶  695-98-7  2,4,6-**基苯磺酰氯  773-64-8

2,4,6-三氯苯硼酸  73852-18-3  2,4-二氟苄胺  72235-52-0

2,4-二氯-5-氟苯乙酮  704-10-9  2,4-二硝基氟苯  70-34-8

2,4-二溴苯磺酰氯  72256-95-2  2,5-二甲基-2,4-己二烯  764-13-6

2,6-吡啶二羧酸单甲酯  7170-36-7  2,6-二氯苯硼酸  73852-17-2

2-氨基-4,6-二甲基嘧啶  767-1?

Urapidil50mg 100mg 200mg>99.50%Cas No. 34661-75-1C20H29N5O3

Ubrogepant (MK-1602)1mg 5mg 10mg>99.50%Cas No. 1374248-77-7C29H26F3N5O3

Pizotifen10mM (in 1mL DMSO) 100mg 300mg 500mg>99.50%Cas No. 15574-96-6C19H21NS

Raclopride5mg 10mg 25mg 50mg>99.50%Cas No. 84225-95-6C15H20Cl2N2O3

Ro 41-1049 hydrochloride5mg 10mg 50mg 100mg>99.50%Cas No. 127917-66-2C12H13ClFN3OS

Rotundine25mg 200mg 500mg 1g>99.50%Cas No. 483-14-7C21H25NO4

Scyllo-Inositol50mg 100mg 200mg 500mg>99.50%Cas No. 488-59-5C6H12O6